Drug-induced lupus erythematosusPiercarlo Sarzi-Puttini
Department of Rheumatology, Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, Milan 20157, Italy
Autoimmunity 38:507-18. 2005
....
Predicting response to anti-TNF treatment in rheumatoid arthritis patientsFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmun Rev 8:431-7. 2009
..To identify the clinical factors predicting failure or a good clinical response in the cohort of RA patients entered in the Lombardy Rheumatology Network (LORHEN) registry after 3 years of treatment with anti-TNF agents...
Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical valueFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmunity 41:111-5. 2008
..The aim of this study was to assess thyroid function as well as the prevalence and clinical value of anti-thyroid antibodies in patients with rheumatoid arthritis (RA)...
Autoimmunity and anti-TNF-alpha agentsFabiola Atzeni
Rheumatology Unit, Department of Rheumatology, University Hospital L Sacco, Via GB Grassi 74, 20157 Milan, Italy
Ann N Y Acad Sci 1051:559-69. 2005
..3% and in 12.9% of adalimumab-treated RA patients. Only limited data on the induction of aPL antibodies during TNF-alpha blocking treatment are available...
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's diseaseFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Rheumatology (Oxford) 51:2141-5. 2012
..To evaluate the potential role of CC chemokine receptor 5 (CCR5)Δ32 polymorphism in the susceptibility to and clinical expression of Behçet's disease (BD) in a cohort of Italian patients...
Do physicians treat symptomatic osteoarthritis patients properly? Results of the AMICA experiencePiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Semin Arthritis Rheum 35:38-42. 2005
..The study was designed to evaluate their prescription modalities to determine whether they matched the recently proposed treatment guidelines for OA (ACR 2000; EULAR 2000; APS 2002)...
Multidisciplinary approach to fibromyalgia: what is the teaching?Piercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Ospedale L Sacco, Via GB Grassi 74, Milan, Italy
Best Pract Res Clin Rheumatol 25:311-9. 2011
..Physical exercise and multimodal cognitive behavioural therapy are the most widely accepted and beneficial forms of non-pharmacological therapy...
Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseasesFabiola Atzeni
L Sacco University Hospital, Milan, Italy
Autoimmun Rev 9:845-8. 2010
..Furthermore, plasma ADMA levels could be used as a simple means of screening SRD patients at higher CV risk who need more aggressive treatment aimed at slowing or reversing the progression of atherosclerosis...
What is the role of rituximab in the treatment of rheumatoid arthritis?Fabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, 20157 Milan, Italy
Autoimmun Rev 6:553-8. 2007
....
Dysfunctional syndromes and fibromyalgia: a 2012 critical digestPiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Clin Exp Rheumatol 30:143-51. 2012
..This review will discuss the recent literature concerning the most common dysfunctional disorders: fibromyalgia syndrome, myalgic encephalomyelitis/chronic fatigue syndrome, and irritable bowel syndrome...
Chronic widespread pain in the spectrum of rheumatological diseasesFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Best Pract Res Clin Rheumatol 25:165-71. 2011
..A misdiagnosis harms the patients and the community. Rheumatologists should be able to recognise and distinguish primary and secondary FM, and need new guidelines and instruments to avoid making mistakes...
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective studyFabiola Atzeni
Rheumatology Unit, Department of Medicine, L Sacco University Hospital, 74 Via GB Grassi, 20157 Milano, Italy
Arthritis Res Ther 8:R3. 2006
..Antinuclear and anti-dsDNA autoantibodies, but not anti-phospholipid autoantibodies, can be induced by adalimumab but to a lower extent than in studies with other anti-TNF blocking agents...
Anti-TNF therapy restores the hypothalamic-pituitary-adrenal axisFabiola Atzeni
Rheumatology Unit, University Hospital L Sacco, Milan, Italy
Ann N Y Acad Sci 1193:179-81. 2010
..Long-term therapy with anti-TNF agents sensitizes the pituitary gland and improves adrenal androgen secretion, thus stimulating an alternative form of anti-inflammatory action...
TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemmaPiercarlo Sarzi-Puttini
Rheumatology Unit, University Hospital L Sacco, Via GB Grassi 74, 20157 Milan, Italy
Autoimmun Rev 4:153-61. 2005
....
Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-upFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmunity 41:87-91. 2008
..Aim of our study was to assess the prevalence and concentration of a panel of organ-specific autoantibodies in patients with RA and to evaluate their relationship with clinical manifestations and treatment efficacy...
Neuroendocrine therapy of fibromyalgia syndrome: an updatePiercarlo Sarzi-Puttini
Rheumatology Unit, University Hospital L Saccco, Milan, Italy
Ann N Y Acad Sci 1193:91-7. 2010
..Studies predicting treatment response indicate that it is useful if not essential to tailor the choice of treatment components to the needs of individual patients...
Psoriatic arthritis: clinical improvement and correlation with hormone axes in etanercept-treated patientsFabiola Atzeni
Rheumatology Unit, University Hospital L Sacco, Milan, Italy
Ann N Y Acad Sci 1193:176-8. 2010
..However, the greater increase in serum cortisol in comparison with serum 17OHP or ASD was related to clinical improvement, which indicates that the improvement was more related to the higher cortisol levels...
Cardiac involvement in systemic rheumatic diseases: An updatePiercarlo Sarzi-Puttini
L Sacco University Hospital, Milan, Italy
Autoimmun Rev 9:849-52. 2010
..As these are all associated with an unfavourable prognosis, it is essential to detect subclinical cardiac involvement in asymptomatic SAD patients, and begin adequate management and treatment early...
Potential target of infliximab in autoimmune and inflammatory diseasesFabiola Atzeni
Rheumatology Unit, L Sacco Hospital, University of Milan, Via GB Grassi 74, 20157 Milan, Italy
Autoimmun Rev 6:529-36. 2007
..A number of other more rare disorders also may be responsive to TNF blockade. We here review the current and prospective roles of infliximab in the treatment of autoimmune diseases and other conditions...
The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseasesFabiola Atzeni
L Sacco University Hospital, Milan, Italy
Autoimmun Rev 9:835-9. 2010
..The effects on the CV system depend on the drug itself, the dose and the period of exposure, and so CV risk should be evaluated before starting treatment with any drug...
Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndromePiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmunity 41:74-9. 2008
..To investigate the prevalence of antipolymer antibody (APA) in patients with fibromyalgia (FM) and to examine its association with FM severity symptoms...
Complementary treatment in fibromyalgia: combination of somatic and abdominal acupunctureCristina Iannuccelli
Rheumatology Unit, Department of Internal Medicine, Sapienza University of Rome, Rome, Italy
Clin Exp Rheumatol 30:112-6. 2012
..As a result, acupuncture could be very useful to relieve pain in a multidisciplinary setting...
Environment and systemic lupus erythematosus: an overviewPiercarlo Sarzi-Puttini
Rheumatology Unit, Department of Rheumatology, L Sacco University Hospital, Milan, Italy
Autoimmunity 38:465-72. 2005
..A better understanding of the etiopathogenetic mechanism of SLE is required in order to clarify the multiple interactions between environmental exposures and genetic factors...
Anti-cytokine antibodies for rheumatic diseasesFabiola Atzeni
L Sacco University Hospital, Rheumatology Unit, Via GB Grassi 74, 20127, Milan, Italy
Curr Opin Investig Drugs 10:1204-11. 2009
..This review describes the efficacy and adverse events associated with anti-cytokine treatments for autoimmune rheumatic diseases...
Switching rheumatoid arthritis treatments: an updateFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmun Rev 10:397-403. 2011
..However, many RA patients can be successfully treated with a second TNF antagonist, especially those discontinuing the first because of secondary failure or adverse events...
Osteoarthritis of the spinePiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Semin Arthritis Rheum 34:38-43. 2005
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritisMaurizio Benucci
Rheumatology Unit, Department of Internal Medicine, Hospital di S Giovanni di Dio, Azienda Sanitaria di Firenze, Florence, Italy
Biologics 7:69-75. 2013
....
Twelve years' experience with etanercept in the treatment of rheumatoid arthritis: how it has changed clinical practiceFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Expert Rev Clin Immunol 8:213-22. 2012
..However, this is closely related to current RA activity and therefore suggests that it is not directly related to the drug. This article considers the published data in terms of clinical practice and changes in the progression of RA...
Treatment strategy in fibromyalgia syndrome: where are we now?Piercarlo Sarzi-Puttini
Clinical Research Scientist, Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Semin Arthritis Rheum 37:353-65. 2008
..The treatment of the fibromyalgia syndrome (FMS) is not standardized and often ineffective, and the course of disease progression is unpredictable...
Osteoarthritis: an overview of the disease and its treatment strategiesPiercarlo Sarzi-Puttini
Division of Rheumatology, L Sacco University Hospital, Milan, Italy
Semin Arthritis Rheum 35:1-10. 2005
..The disease course and patient's requirements often change over time, thus requiring a periodic review and readjustment of therapy rather than the rigid continuation of a single treatment...
Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effectFausto Salaffi
Department of Rheumatology, Polytechnic University of the Marche Medical School, Via dei Colli 52, Jesi, Ancona, Italy
Arthritis Res Ther 11:R125. 2009
....
Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisalRoberto Caporali
Rheumatology Unit, University of Pavia, IRCCS Policlinico S Matteo Foundation, 27100 Pavia, Italy
Autoimmun Rev 8:274-80. 2009
..As the first published registry of anti-TNFalpha-treated patients in Italy, Lombardy Rheumatology Network (LORHEN) is already making its contribution in this direction...
Autoantibody production in patients treated with anti-TNF-alphaFabiola Atzeni
Rheumatology Unit, University Hospital L Sacco, Via GB Grassi, 74, 20157 Milano, Italy
Expert Rev Clin Immunol 4:275-80. 2008
..This has led some authors to conclude that it is necessary to add methotrexate to infliximab in order to reduce the risk of the appearance of anti-idiotype autoantibodies...
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registryFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmun Rev 12:225-9. 2012
..To evaluate the risk of serious infections (SIs) in RA patients receiving anti-TNF therapy on the basis of the data included in the GISEA register...
Tumor necrosis factors blocking agents: analogies and differencesMaurizio Benucci
Rheumatology Unit, Department of Internal Medicine, Hospital di S Giovanni di Dio, Azienda Sanitaria di Firenze, Italy
Acta Biomed 83:72-80. 2012
..Reviewing the biology of transmembrane TNF-alpha and its interaction with anti-TNF agents will contribute to understanding the bases of differential clinical efficacy of these promising treatment modalities...
Chronic widespread pain: from peripheral to central evolutionPiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Best Pract Res Clin Rheumatol 25:133-9. 2011
..The two models (neurochemical and biopsychosocial) also affect our ability to find therapeutic answers...
Resistant cases of psoriatic arthritis: how to manage themFabiola Atzeni
Rheumatology Unit, L Sacco Hospital, Milan, Italy
J Rheumatol Suppl 83:73-5. 2009
..A number of clinical trials have shown that tumor necrosis factor antagonists are generally safe and efficacious in the treatment of PsA, and can inhibit the progression of radiographic damage...
Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitisFabiola Atzeni
Rheumatology Unit, L, Sacco Hospital, University of Milan, Via G, B, Grassi 74, 20127 Milan, Italy
Arthritis Res Ther 10:R51. 2008
..The purpose of this study was to investigate the prevalence of cyclic citrullinated peptide antibodies (anti-CCP) in patients with primary Sjögren syndrome (pSS) and its correlation with clinical and laboratory data...
Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritisPiercarlo Sarzi-Puttini
Rheumatology Unit, University Hospital L Sacco, Milan, Italy
Rheumatol Int 21:234-8. 2002
..The aim of this study was to evaluate the efficacy and tolerability of long-term treatment with cyclosporin A (CsA) in patients with psoriatic arthritis (PsA)...
Increased neural sympathetic activation in fibromyalgia syndromePiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, 20157 Milano, Italy
Ann N Y Acad Sci 1069:109-17. 2006
..This review discusses the general aspects of the altered HPA and ANS, sympathetic overactivity, and alterations in cardiovascular autonomic responses to gravitational stimuli...
Preclinical impairment of coronary flow reserve in patients with rheumatoid arthritisFabiola Atzeni
Rheumatology Unit, L Sacco Hospital, University of Milan, Milan, Italy
Ann N Y Acad Sci 1108:392-7. 2007
..CFR is early reduced in RA patients without clinical evidence of heart disease as a result of impaired microcirculation. CFR seems a useful technique able to follow-up and to assess effects of new drugs on RA patients...
Primary and secondary autoimmune neutropeniaFranco Capsoni
Rheumatology Unit, Istituto Ortopedico Galeazzi, University of Milan, Milan, Italy
Arthritis Res Ther 7:208-14. 2005
..Granulocyte colony-stimulating factor is a proven treatment in patients with AIN of all types and is now preferred to other possible therapies...
Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a reviewFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, 20157 Milan, Italy
Autoimmun Rev 4:144-52. 2005
..We here review the current and prospective roles of infliximab in the treatment of autoimmune diseases and other conditions that do not currently have FDA or EMEA approval...
Different effects of biological drugs in rheumatoid arthritisFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmun Rev 12:575-9. 2013
..Finally, although these drugs improve the quality of life of RA patients, they considerably increase direct medical costs...
New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis)Piercarlo Sarzi-Puttini
Rheumatology Unit, University Hospital L Sacco, Via GB Grassi 74, 20157 Milan, Italy
Curr Opin Rheumatol 16:287-92. 2004
..Purpose of this review is to summarize new clinical, pathogenetic and therapeutic insights of this disease...
Combined therapeutic approach: inflammatory bowel diseases and peripheral or axial arthritisFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milano, Italy
World J Gastroenterol 15:2469-71. 2009
....
Is it antiphospholipid syndrome?Maria Chiara Ditto
Rheumatology Unit, L Sacco University Hospital, Via G B Grassi 74, 20157 Milano, Italy
Int J Rheumatol 2010:932157. 2010
..This case not only reminds us of the diagnostic challenges of bacterial endocarditis, but also underlines the need for a critical application of antiphospholipid syndrome diagnostic criteria...
PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's diseaseFabiola Atzeni
Rheumatology Unit, Ospedale L Sacco, Milan, Italy
Clin Exp Rheumatol 29:S38-43. 2011
..To investigate potential associations between the PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA (GpIIIa) gene and venous thrombosis and other clinical manifestations in Italian patients with Behçet's disease (BD)...
Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others)Fabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Rheum Dis Clin North Am 32:413-26, viii. 2006
..Serum matrix Gla protein may be a marker of osteometabolic syndromes that cause hyperostosis and plays a role in Milwaukee shoulder syndrome...
Introduction: osteoarthritis in the third millennium: a new era for an old disease?Mario Carrabba
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Semin Arthritis Rheum 34:1-2. 2005
Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?Maurizio Rizzi
Center for Sleep and Respiratory Disorders, Rheumatology Unit, University Hospital L Sacco, Milan, Italy
J Rheumatol 31:1193-9. 2004
..We evaluated the presence of CAP in patients with fibromyalgia (FM) compared to healthy controls...
Validation of the reflux disease questionnaire for an Italian population of patients with gastroesophageal reflux diseaseFabio Pace
Department of Clinical Sciences, Division of Gastroenterology, L Sacco University Hospital, Milan, Italy
Eur J Gastroenterol Hepatol 20:187-90. 2008
..As an English and a German version of the RDQ exist, but not an Italian one, we aimed at translating the RDQ into Italian and evaluating its reliability for the use of Italian-speaking GERD patients...
Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapyRainer H Straub
Department of Internal Medicine I, Laboratory of Neuroendocrinoimmunology, University Medical Center, Regensburg, Germany
J Rheumatol 32:1253-8. 2005
..Since tumor necrosis factor (TNF) alters production of these hormones, we investigated changes of these hormones during anti-TNF antibody (anti-TNF) therapy with adalimumab in longstanding RA...
An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritisPiercarlo Sarzi-Puttini
Unità Operativa di Reumatologia, University Hospital L Sacco, Via G B Grassi 74, 20157 Milan, Italy
Rheumatol Int 25:15-22. 2005
....
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritisFranco Capsoni
Department of Internal Medicine, Ospedale Maggiore Policlinico, IRCCS, University of Milan, Milan, Italy
Arthritis Res Ther 7:R250-5. 2005
....
The role of echocardiographic techniques in connective tissue diseasesMaurizio Turiel
Department of Cardiology, Istituto Galeazzi, University of Milan, Via Galeazzi 4, 20161 Milano, Italy
Autoimmun Rev 4:171-7. 2005
....
Systemic lupus erythematosus, atherosclerosis, and autoantibodiesSandra Zampieri
Division of Rheumatology, University of Padova, Via Giustiniani 2, I-35128 Padua, Italy
Ann N Y Acad Sci 1051:351-61. 2005
....
Physical and rehabilitative approaches in osteoarthritisFeliciantonio Di Domenica
Rehabilitation Department, Istituto Ortopedico G Pini, Milano, Italy
Semin Arthritis Rheum 34:62-9. 2005
Influence of coping skills on health-related quality of life in patients with systemic lupus erythematosusSilvana Rinaldi
University of Padova, Padova, Italy
Arthritis Rheum 55:427-33. 2006
..Strategies that show a passive attitude and joint pain seem to impair these patients' HRQOL...
Polymyositis-dermatomyositis and infectionsSandra Zampieri
University of Padova, Division of Rheumatology, Department of Clinical and Experimental Medicine, Italy
Autoimmunity 39:191-6. 2006
..In this review, the increased risk of developing infections in these patients is also underlined and published data are reported...
Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory actionRainer H Straub
Laboratory of Experimental Rheumatology and Neuroendocrino-Immunology, Division of Rheumatology, Department of Internal Medicine I, University Hospital, 93042 Regensburg, Germany
Arthritis Rheum 54:2039-46. 2006
Long-term prognosis and causes of death in systemic lupus erythematosusAndrea Doria
Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy
Am J Med 119:700-6. 2006
..We studied survival rate, prognostic factors, and causes of death in patients with systemic lupus erythematosus (SLE), particularly focusing on the influence of disease severity...
Antigen preparation for immunological studies in systemic autoimmune diseasesSandra Zampieri
Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy
Ann N Y Acad Sci 1109:193-202. 2007
..In this review an overview of the different biochemical methods of antigen preparation and the specific methodological applications is given, also describing potential critical aspects and benefits of the different protocols...
Organ specific-autoantibodies: their role as markers and predictors of diseasePiercarlo Sarzi-Puttini
Autoimmunity 41:1-10. 2008
Estrogens in pregnancy and systemic lupus erythematosusAndrea Doria
Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy
Ann N Y Acad Sci 1069:247-56. 2006
..This occurrence could lead to a lower-than-expected increase of IL-6, accounting for the low humoral immune response and the low disease activity observed in the third trimester of pregnancy in such patients...
Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritisRainer H Straub
Laboratory of Experimental Rheumatology and Neuroendocrino Immunology, Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany
Arthritis Rheum 58:976-84. 2008
..We undertook this study to investigate the predictive value of hypothalamic-pituitary-adrenal (HPA) axis hormones for clinical improvement during anti-TNF therapy...